Vimarsana
Biggest News Aggregation in the World

Page 29 - Peter Openshaw News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Openshaw. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Openshaw Today - Breaking & Trending Today

Pandemic curbs linked to early start to Europe's winter flu season - Vimarsana News

Pandemic curbs linked to early start to Europe's winter flu season

By Natalie Grover LONDON (Reuters) - Pandemic restrictions that hampered the circulation of viruses other than COVID-19 could be behind the unseasonab...

Source: wtbx.com
Gibraltar: UK police asked to help with inquiry into alleged government corruption - Vimarsana News

Gibraltar: UK police asked to help with inquiry into alleged government corruption

Royal Gibraltar police ask British counterparts to investigate alleged data breach in interests of ‘transparency’

Defenses Down: COVID Antibodies in Nose Decline First - Vimarsana News

Defenses Down: COVID Antibodies in Nose Decline First

WEDNESDAY, Dec. 21, 2022 (HealthDay News) -- Researchers think they’ve figured out why people can become reinfected with COVID-19, despite immunity gained from either vaccination or a previous infection.

Source: ktbs.com
COVID-19 antibodies decline faster in the nose - Vimarsana News

COVID-19 antibodies decline faster in the nose

Antibodies produced in the nose -- the first line of defense against respiratory viruses like COVID-19 -- decline faster than antibodies found in the bloodstream, British scientists say.

Source: upi.com
First-line defences against COVID-19 are short-lived and may explain reinfection | Imperial News - Vimarsana News

First-line defences against COVID-19 are short-lived and may explain reinfection | Imperial News

REINFECTION DEFENCES - A new study finds that antibodies produced in the nose decline 9 months after infection, while those found in the blood last at least a year.